MCA logo
MCA logo



The FDA has Granted Full Approval to Pembrolizumab for the Treatment of Unresectable Or Msi-H Or Dmmr Solid Tumour

This marks the first-ever FDA approval for immunotherapy based on a predictive biomarker, regardless of solid tumour type.

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

taguig vs makati embos
Taguig City’s Compassionate Response to Makati’s Health Center Closure For Embos

The Taguig City government has taken a stance to provide essential healthcare services to the residents of enlisted men’s barrios or “embos”. The embos are the people who find themselves without access to healthcare facilities following the sudden closure of Makati’s health centers. The dispute between the two cities involved the backdrop of legal decisions, administrative back-and-forths, and a growing concern for the well-being of the affected residents.

Read More »